In the BioHarmony Drug Report Database

"Preview" Icon

Methylthioninium chloride

Provayblue (methylene blue) is a small molecule pharmaceutical. Methylene blue was first approved as Provayblue on 2016-04-08. It is used to treat cyanosis, herpes simplex, lithiasis, methemoglobinemia, and poisoning amongst others in the USA.

 

Trade Name

 

Provayblue
 

Common Name

 

methylene blue
 

ChEMBL ID

 

CHEMBL550495
 

Indication

 

cyanosis, herpes simplex, lithiasis, methemoglobinemia, poisoning, urinary tract infections
 

Drug Class

 

Image (chem structure or protein)

Methylthioninium chloride structure rendering